Effect of chronic renal insufficiency on hepatic and renal UDP-glucuronyltransferases in rats

Drug Metabolism and Disposition

Volumn 34, Issue 4, 2006, Pages 621-627

  Yu, Chuanhui ^a   Ritter, Joseph K ^a   Krieg, Richard J ^a   Rege, Bhaskar ^a   Karnes, Thomas H ^a   Sarkar, Mohamadi A ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b Clinical Evaluation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; ESTRADIOL; GLUCURONOSYLTRANSFERASE; HYMECROMONE; MORPHINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATALYSIS; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME REGULATION; FOOD INTAKE; GLUCURONIDATION; HORMONE METABOLISM; KIDNEY MICROSOME; LIVER MICROSOME; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ANIMALS; DISEASE MODELS, ANIMAL; GLUCURONOSYLTRANSFERASE; ISOENZYMES; KIDNEY; LIVER; MALE; MALNUTRITION; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; RENAL INSUFFICIENCY, CHRONIC;

ANIMALIA;

EID: 33645101771     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.105.006601     Document Type: Article

References (40)

1. Ali M, Nicholls PJ, and Yoosuf A (1979) The influence of old age and of renal failure on hepatic glucuronidation in the rat. Br J Pharmacol 66:498P-499P.
2. Anders MW (1980) Metabolism of drugs by the kidney. Kidney Int 18:636-647.
3. Balant L, Francis RJ, Tozer TN, Marmy A, Tschopp JM, and Fabre J (1980) Influence of renal failure on the hepatic clearance of bufuralol in man. J Pharmacokinet Biopharm 8:421-438.
4. Brunelle FM and Verbeeck RK (1996) Glucuronidation of diflunisal in liver and kidney microsomes of rat and man. Xenobiotica 26:123-131.
5. Coughtrie MW, Burchell B, and Bend JR (1987) Purification and properties of rat kidney UDP-glucuronosyltransferase. Biochem Pharmacol 36:245-251.
6. Falany CN and Tephly TR (1983) Separation, purification and characterization of three isoenzymes of UDP-glucuronyltransferase from rat liver microsomes. Arch Biochem Biophys 227:248-258.
7. Fisher MB, Paine MF, Strelevitz TJ, and Wrighton SA (2001) The role of hepatic and extrahepatic UDP-glucuronosyltransferase in human drug metabolism. Drug Metab Rev 33:273-297.
8. Gibson TP (1986) Renal disease and drug metabolism: an overview. Am J Kidney Dis 8:7-17.
9. Hanioka N, Jinno H, Tanaka-Kagawa T, Nishimura T, and Ando M (2001) Determination of UDP-glucuronosyltransferase UGT1A6 activity in human and rat liver microsomes by HPLC with UV detection. J Pharm Biomed Anal 25:65-75.
10. Innocenti F, Iyer L, Ramirez J, Green MD, and Ratain MJ (2001) Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7. Drug Metab Dispos 29:686-692.
11. Ishii Y, Tsuruda K, Tanaka M, and Oguri K (1994) Purification of a phenobarbital-inducible morphine UDP-glucuronosyltransferase isoform, absent from Gunn rat liver. Arch Biochem Biophys 315:345-351.
12. Iwano H, Yokota H, Ohgiya S, and Yuasa A (1999) The significance of amino acid residue Asp446 for enzymatic stability of rat UDP-glucuronosyltranferase UGT1A6. Arch Biochem Biophys 363:116-120.
13. Jansen PL, Mulder GJ, Burchell B, and Bock KW (1992) New developments in glucuronidation research: report of a workshop on "glucuronidation, its role in health and disease". Hepatology 15:532-544.
14. King C, Finley B, and Franklin R (2000) The glucuronidation of morphine by dog liver microsomes: identification of morphine-6-O-glucuronide. Drug Metab Dispos 28:661-663.
15. King CD, Green MD, Rios GR, Coffman BL, Owens IS, Bishop WP, and Tephly TR (1996) The glucuronidation of exogenous and endogenous compounds by stably expressed rat and human UDP-glucuronosyltransferase 1.1. Arch Biochem Biophys 332:92-100.
16. King CD, Rios GR, Green MD, Mackenzie PI, and Tephly TR (1997) Comparison of stably expressed rat UGT1.1 and UGT2B1 in the glucuronidation of opioid compounds. Drug Metab Dispos 25:251-255.
17. Krishnaswamy K and Naidu AN (1977) Microsomal enzymes in malnutrition as determined by plasma half life of antipyrine. Br Med J 26:538-540.
18. Leblond F, Guevin C, Demers C, Pellerin I, Gascon-Barre M, and Pichette V (2001) Down-regulation of hepatic cytochrome P450 in chronic renal failure. J Am Soc Nephrol 12:326-332.
19. Leblond FA, Giroux L, Villeneuve JP, and Pichette V (2000) Decreased in vivo metabolism of drugs in chronic renal failure. Drug Metab Dispos 28:1317-1320.
20. Le Guellec C, Lacarelle B, Villard PH, Point H, Catalin J, and Durand A (1995) Glucuronidation of propofol in microsomal fractions from various tissues and species including humans: effect of different drugs. Anesth Analg 81:855-861.
21. Lepine J, Bernard O, Plante M, Tetu B, Pelletier G, Labrie F, Belanger A, and Guillemette C (2004) Specificity and regioselectivity of the conjugation of estradiol, estrone and their catecholestrogen and methoxyestrogen metabolites by human uridine diphosphoglucuronosyltransferases expressed in endometrium. J Clin Endocrinol Metab 89:5222-5232.
22. Mandl J, Banhegyi G, Kalapos MP, and Garzo T (1995) Increased oxidation and decreased conjugation of drugs in the liver caused by starvation. Altered metabolism of certain aromatic compounds and acetone. Chem Biol Interact 96:87-101.
23. Miles KK, Stern ST, Smith PC, Kessler F, Ali S, and Ritter J (2005) An investigation of human and rat liver microsomal mycophenolic acid glucuronidation: evidence for a principal role of UGT1A enzymes and species differences in UGT1A specificity. Drug Metab Dispos 33:1513-1520.
24. Miners JO and Mackenzie PI (1991) Drug glucuronidation in humans. Pharmacol Ther 51:347-369.
25. Monteith DK, Michalopoulos G, and Strom SC (1990) Conjugation of chemical carcinogens by primary cultures of human hepatocytes. Xenobiotica 20:753-763.
26. Narayanan R, LeDuc B, and Williams DA (2000) Determination of the kinetics of rat UDPglucuronosyltransferases (UGTs) in liver and intestine using HPLC. J Pharm Biomed Anal 22:527-540.
27. Peters WHM and Jansent PLM (1988) Immunocharacterization of UDP-glucuronosyltransferases isoenzymes in human liver, intestine and kidney. Biochem Pharmacol 37:564-567.
28. Pritchard M, Fournel-Gigleux S, Siest G, Mackenzie P, and Magdalou J (1993) A recombinant phenobarbital-inducible rat liver UDP- glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols and carboxylic acids. Mol Pharmacol 45:42-50.
29. Rege B, Krieg R, Gao N, and Sarkar MA (2003) Down-regulation of hepatic CYP3A in chronic renal insufficiency. Pharm Res (NY) 20:1600-1606.
30. Ritter JK (2000) Role of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions. Chem Biol Interact 129:171-193.
31. Ritter JK, Kessler FK, Thompson MT, Grove AD, Auyeung DJ, and Fisher RA (1999) Expression and inducibility of the human bilirubin UDP- glucuronosyltransferase UGT1A1 in liver and cultured primary hepatocytes: evidence for both genetic and environmental influences. Hepatology 30:476-484.
32. Sarkar MA, Hunt C, Guzelian PS, and Karnes HT (1992) Characterization of human liver cytochromes P-450 involved in theophylline metabolism. Drug Metab Dispos 20:31-37.
33. Senafi SB, Clarke DJ, and Burchell B (1994) Investigation of the substrate specificity of a cloned expressed human bilirubin UDP- glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation. Biochem J 303:233-240.
34. Shelby MK, Cherrington NJ, Vansell NR, and Klaassen CD (2002) Tissue mRNA expression of the rat UDP-glucuronosyltransferase gene family. Drug Metab Dispos 31:326-333.
35. Singlas E, Pioger JC, Taburet AM, Colin JN, and Fillastre JP (1989) Zidovudine disposition in patients with severe renal impairment: influence of hemodialysis. Clin Pharmacol Ther 46:190-197.
36. Tephly TR and Burchell B (1990) UDP-glucuronosyltransferases: a family of detoxifying enzymes. Trends Pharmacol Sci 11:276-279.
37. Touchette MA and Slaughter RL (1991) The effect of renal failure on hepatic drug clearance. DICP-Ann Pharmacother 25:1214-1224.
38. Tukey RH and Strassburg CP (2000) Human UDP-glucuronosyltransferases: metabolism, expression and disease. Annu Rev Pharmacol Toxicol 40:581-616.
39. Turgeon D, Carrier JS, Levesque E, Hum DW, and Belanger A (2001) Relative enzymatic activity, protein stability and tissue distribution of human steroid-metabolizing UGT2B subfamily members. Endocrinology 142:778-787.
40. Walter-Sack I and Klotz U (1996) Influence of diet and nutritional status on drug metabolism. Clin Pharmacokinet 31:47-64.